Search

A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer, regardless of prior CDK 4/6 inhibitors, ESR1 or PI3K pathway mutations.

… Wednesday, December 11, 2024 A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative (ER

The largest, most comprehensive study of its kind from Memorial Sloan Kettering Cancer Center finds that the biology of colorectal cancer in people under 50 is very similar to the disease in older people and more aggressive treatment of younger patients may not be warranted.

… Wednesday, August 18, 2021 Could colorectal cancer in people under 50 years old be biologically different and more aggressive than colorectal cancer in older people? That’s what some researchers have proposed as people in their 20s, 30s, and 40s face a disturbing rise in colorectal cancer — people who

El estudio más grande y más completo de su tipo, realizado por el Memorial Sloan Kettering Cancer Center, concluye que la biología del cáncer colorrectal en personas menores de 50 años es muy similar a la de los pacientes de mayor edad, y que podría no estar justificado aplicar tratamientos más agresivos en los pacientes más jóvenes.

… Wednesday, August 18, 2021 ¿Podría el cáncer colorrectal en las personas menores de 50 años ser biológicamente diferente y más agresivo que el cáncer colorrectal en las personas mayores? Eso es lo que algunos investigadores han propuesto, ya que las personas de 20, 30 y 40 años se enfrentan a un aumento

Memorial Sloan Kettering researchers will explore "C dots" for tumor detection and treatment.

… Friday, May 1, 2009 Summary Memorial Sloan Kettering researchers will explore “C dots” for tumor detection and treatment. Researchers Will Explore “C Dots” for Tumor Detection and Treatment What if a tumor could be lit up by a fluorescent imaging agent, or probe, that is safe, biologically stable, and

MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month.

… Friday, November 5, 2021 MSK’s  Pamela Drullinsky , MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47  for breast cancer awareness month. The story highlighted Rosa Martinez’s personal

La Dra. Pamela Drullinsky, oncóloga médica de MSK especialista en mamas y directora médica del sitio de la Red Regional de Atención MSK Nassau, acompañó recientemente a una de sus pacientes en un segmento del Noticiero Telemundo 47 por el mes de concientización sobre el cáncer de mama.

… Friday, November 5, 2021 La Dra. Pamela Drullinsky , oncóloga médica de MSK especialista en mamas y directora médica del sitio de la Red Regional de Atención MSK Nassau, acompañó recientemente a una de sus pacientes en un segmento del Noticiero Telemundo 47  por el mes de concientización sobre el cáncer

Nikki Chotas, who uses the pronouns they/them, has dedicated much of their life to speaking up for and working to empower those who may feel helpless and without a voice. They attribute their pursuits in part to feeling voiceless in their younger years.

… Wednesday, June 29, 2022 Nikki Chotas, who uses the pronouns they/them, has dedicated much of their life to speaking up for and working to empower those who may feel helpless and without a voice. They attribute their pursuits in part to feeling voiceless in their younger years.   “I had dark days. I

Cancer is tough, no matter the age. But adolescents and young adults with cancer face a whole host of unique challenges, including delayed diagnoses. MSK created an Adolescent and Young Adult (AYA at MSK) program which unites experts across 16 specialties.

… Thursday, September 17, 2020 Cancer is tough, no matter the age. But adolescents and young adults with cancer face a whole host of unique challenges, including delayed diagnoses. For years, MSK has worked to close the gap between pediatric and adult patients and to improve the experience for people in

Childhood leukemia expert Melvyn Greaves received The Society of Memorial Sloan Kettering Prize at the 2018 Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) commencement.

… Thursday, June 7, 2018 Summary Childhood leukemia expert Melvyn Greaves received The Society of Memorial Sloan Kettering Prize at the 2018 Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) commencement. At this year’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences

Experts at MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer are devoted to creating the best treatment plan for you and your family.

… Thursday, March 25, 2021 Kellee Strong clearly remembers her first thought when a local doctor broke the news that Kellee had cancer, and it had spread to several organs: “I’m not even going to see my kids graduate from high school.” At age 42, she was enjoying a full life, with a career in the court